Related references
Note: Only part of the references are listed.The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
Xinyu Geng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer
Anita Annahazi et al.
BRITISH JOURNAL OF CANCER (2016)
High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma
Nada Salem et al.
FUTURE ONCOLOGY (2016)
Matrix metalloproteinase 9-1562C/T polymorphism increased protein levels in patients with colorectal cancer in a sample from southeastern Brazil
C. R. Hoelzle et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
Barbara Gruenwald et al.
MOLECULAR CANCER RESEARCH (2016)
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis
Da-wei Sun et al.
CANCER EPIDEMIOLOGY (2015)
Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis
Fanghui Ren et al.
PLOS ONE (2015)
Immunoexpression of ROCK-1 and MMP-9 as prognostic markers in breast cancer
Jenifer Bottino et al.
ACTA HISTOCHEMICA (2014)
The Role of Matrix Metalloproteinases in Colorectal Cancer
Anan H. Said et al.
CANCERS (2014)
Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A Meta-analysis
Jian Song et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Expression of matrix metalloproteinases in human breast cancer tissues
Chellakkan Selvanesan Benson et al.
DISEASE MARKERS (2013)
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Jonathan Welti et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
Karin Soderlund Leifler et al.
JOURNAL OF IMMUNOLOGY (2013)
Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis
Mumu Shi et al.
MOLECULAR BIOLOGY REPORTS (2013)
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients
Shu Zhao et al.
MEDICAL ONCOLOGY (2013)
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
Laszlo Herszenyi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Overexpression of matrix metalloproteinase-7 and-9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome
Helge Stenvold et al.
LUNG CANCER (2012)
Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis
Dan Liu et al.
PLOS ONE (2012)
Developmental and Pathological Angiogenesis
Alicia S. Chung et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Tumor and Salivary Matrix Metalloproteinase Levels Are Strong Diagnostic Markers of Oral Squamous Cell Carcinoma
Marni Stott-Miller et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Matrix metalloproteinases and their clinical relevance in urinary bladder cancer
Tibor Szarvas et al.
NATURE REVIEWS UROLOGY (2011)
MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases
Eliana Pivetta et al.
BREAST CANCER RESEARCH (2011)
Matrix metalloproteinase (MMP)-7 in salivary gland cancer
Heikki Luukkaa et al.
ACTA ONCOLOGICA (2010)
Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer
Kouichirou Tahara et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Study of matrix metalloproteinases and their inhibitors in prostate cancer
S. Escaff et al.
BRITISH JOURNAL OF CANCER (2010)
Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
Laurie E. Littlepage et al.
CANCER RESEARCH (2010)
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung
Sonam A. Shah et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
Andrea Koehrmann et al.
BMC CANCER (2009)
Fecal Cyclooxygenase 2 Plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal Cancer Screening
Tetsunari Takai et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
Hui Liu et al.
CANCER SCIENCE (2008)
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer
Wei-de Zhong et al.
ONCOLOGY (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients
Joan Maurel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment
Joyce C. Tse et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma
Young Deuk Choi et al.
JOURNAL OF UROLOGY (2007)
Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells
Sara A. Illman et al.
JOURNAL OF CELL SCIENCE (2006)
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma
ZH Gao et al.
MODERN PATHOLOGY (2006)
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
CF Chantrain et al.
EUROPEAN JOURNAL OF CANCER (2006)
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer
K Przybylowska et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor
Seakwoo Lee et al.
CELL RESEARCH (2006)
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
DC Radisky et al.
NATURE (2005)
EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair
EE Gabison et al.
BIOCHIMIE (2005)
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer
KD Miller et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
PL Torng et al.
GYNECOLOGIC ONCOLOGY (2004)
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer -: MMP-9 correlates to the grade and the stage
K Aglund et al.
GYNECOLOGIC ONCOLOGY (2004)
Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: Relationship with prognosis
MI Ahmed et al.
DISEASE MARKERS (2004)
Constitutive and inducible expression and regulation of vascular endothelial growth factor
KP Xie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma
M Takahashi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2002)
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas
M Ueda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Role of matrix metalloproteinases in colorectal carcinogenesis
MJ Heslin et al.
ANNALS OF SURGERY (2001)
The design, structure, and therapeutic application of matrix metalloproteinase inhibitors
JW Skiles et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Development of matrix metalloproteinase inhibitors in cancer therapy
M Hidalgo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter
WW Noll et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Generation and degradation of human endostatin proteins by various proteinases
M Ferreras et al.
FEBS LETTERS (2000)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging
EA Baker et al.
BRITISH JOURNAL OF SURGERY (2000)
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity
A Noël et al.
ONCOGENE (2000)
Extrinsic regulators of epithelial tumor progression: metalloproteinases
G Bergers et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2000)
Share Paper
